Skip to main content

Breadcrumb

  1. Home

Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney

Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)

Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery

Greater Occipital Nerve Block Versus Metoclopramide

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Greater Occipital Nerve Block Versus Metoclopramide

Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC

Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome

Thermal Imaging as a Potential Diagnostic Tool of Nasal Airflow

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Thermal Imaging as a Potential Diagnostic Tool of Nasal Airflow

Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma

Effect of Consumption of Caraway on Treatment of Obesity

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Effect of Consumption of Caraway on Treatment of Obesity

Nivolumab in Eliminating Minimal Residual Disease and Preventing Relapse in Patients With Acute Myeloid Leukemia in Remission After Chemotherapy

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Nivolumab in Eliminating Minimal Residual Disease and Preventing Relapse in Patients With Acute Myeloid Leukemia in Remission After Chemotherapy

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 112
  • Page 113
  • Page 114
  • Page 115
  • Page 116
  • Page 117
  • Page 118
  • Page 119
  • Page 120
  • …
  • Next page Next
  • Last page Last
Subscribe to